By consolidating these insights, TRPM8 emerges as a prospective therapeutic target for managing digestive tract inflammation, tumors, and sensory and functional disorders, showcasing promise as a novel diagnostic, prognostic, and therapeutic marker across esophageal, gastric, and colon cancer research spheres, with substantial potential for future advancement. This evidence concerns the gene TRPM8 and malignant colon neoplasm.